Literature DB >> 11927429

Assessment of vision-related function in patients with age-related macular degeneration.

Paul J Mackenzie1, Tom S Chang, Ingrid U Scott, Mark Linder, Dawn Hay, William J Feuer, Keith Chambers.   

Abstract

OBJECTIVE: To investigate the validity of the visual function index (VF-14) in assessing visual function in patients with age-related macular degeneration (AMD).
DESIGN: Prospective noncomparative observational case series. PARTICIPANTS: One hundred fifty-nine consecutive patients attending a sole practitioner's academic retina-only clinic from May 1998 through August 1998 and from May 1999 through August 1999. MAIN OUTCOME MEASURES: Correlations were calculated between the VF-14 scores and the medical outcomes study 36-item short form (SF-36), weighted comorbidity scale, visual acuity and clinical AMD severity (stage), and vision self-assessment scales. Documentation of the severity of macular degeneration was performed by a sole examiner.
RESULTS: There was a moderately strong correlation between visual acuity and trouble with vision (r = 0.51), satisfaction with vision (r = -0.50), and overall quality of vision (r = -0.56). A strong correlation was noted between VF-14 score and patients' self-rating of amount of trouble with vision (r = -0.67), satisfaction with vision (r = 0.62), and overall quality of vision (r = 0.67). In comparison, correlations between SF-36 score and patients' self-rating of amount of trouble with vision, satisfaction with vision, and overall quality of vision ranged from r = 0.37 to r = -0.40. Linear regression analysis for the overall study population indicated that AMD severity was not an independently significant predictor of VF-14 score after adjusting for visual acuity. However, among patients with 20/20 vision in the better eye, AMD severity was an independently significant predictor of VF-14 score after adjusting for visual acuity in the worse eye.
CONCLUSIONS: The VF-14 exhibits a considerable degree of validity as a measure of functional impairment in patients with AMD. Age-related macular degeneration severity was an independently significant predictor of VF-14 score in the group of patients with 20/20 vision in the better eye, but this did not hold true for the overall study population. Age-related macular degeneration is associated with substantial impairment in reported visual function.

Entities:  

Mesh:

Year:  2002        PMID: 11927429     DOI: 10.1016/s0161-6420(01)01021-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardt-like retinal dystrophy.

Authors:  I M MacDonald; M Hébert; R J Yau; S Flynn; J Jumpsen; M Suh; M T Clandinin
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.

Authors:  Anne S Lindblad; Traci E Clemons
Journal:  Arch Ophthalmol       Date:  2005-09

3.  Quality of life and visual function in patients with intermediate uveitis.

Authors:  C C Murphy; E H Hughes; N A Frost; A D Dick
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life.

Authors:  Alex W Hewitt; V Swetha Jeganathan; Juanita E Kidd; Konrad Pesudovs; Nitin Verma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

Review 5.  Spare the rod and spoil the eye.

Authors:  G B Arden; R L Sidman; W Arap; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case.

Authors:  D H Smith; P Fenn; M Drummond
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

7.  Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain.

Authors:  J J Navarro Esteban; M Solera Martínez; P García Navalón; O Piñar Serrano; J R Cerrillo Patiño; M E Calle Purón; V Martínez-Vizcaíno
Journal:  Qual Life Res       Date:  2007-11-17       Impact factor: 4.147

8.  Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.

Authors:  Robert P Finger; Monika Fleckenstein; Frank G Holz; Hendrik P N Scholl
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

9.  [Visual acuity, quality of life, and patient satisfaction after PDT treatment in AMD patients].

Authors:  F Krummenauer; M Braun; H B Dick
Journal:  Ophthalmologe       Date:  2004-07       Impact factor: 1.059

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.